Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Abstract
Authors
L. Betegón Nicolás G. Escolar Albaladejo C. Canal Fontcuberta M. de Salas-Cansado D. Rubio-Rodríguez C. Rubio-Terrés G.allego V Fernández